Information Provided By:
Fly News Breaks for November 4, 2015
VSI
Nov 4, 2015 | 15:41 EDT
BofA/Merill analyst Curtis Nagle reiterated his Underperform rating on Vitamin Shoppe and $30 price target on shares. Nagle said comp and industry trends remain weak and lack a compelling catalyst for improvement, continues to view current growth trajectory as aggressive given sector maturity, and believes it will be difficult for the company to meet or beat the high-end of FY15 guidance.
News For VSI From the Last 2 Days
There are no results for your query VSI